The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation

British Journal of Cancer

Volumn 84, Issue 10, 2001, Pages 1363-1371

  Paju, A ^a   Sorsa, T ^b   Tervahartiala, T ^b   Koivunen, E ^b   Haglund, C ^a   Leminen, A ^a   Wahlstrom T ^a   Salo, T ^c   Stenman, U H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Cyst fluid; MMP 2; MMP 9; Ovarian cancer; TATI; Trypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; APROTININ; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; ISOENZYME; TRYPSIN; TRYPSINOGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CYST FLUID; FEMALE; FLUOROMETRY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; METASTASIS; NEUTROPHIL; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN DEGRADATION; ZYMOGRAPHY;

ADOLESCENT; ADULT; AGED; COLLAGENASES; CYSTADENOCARCINOMA, MUCINOUS; ENZYME ACTIVATION; ENZYME PRECURSORS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; OVARIAN CYSTS; OVARIAN NEOPLASMS; TRYPSIN; TRYPSINOGEN;

EID: 0035906848     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1806     Document Type: Article

References (55)

1. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
2. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role of desmoplastic fibroblasts
3. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors
4. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers
5. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase / collagenase) to the metastatic phenotype in transformed rat embryo cells
6. MMP-2 release and activation in ovarian carcinoma: The role of fibroblasts
7. Activity of type IV collagenases in benign and malignant breast disease
8. Levels of metalloproteinases in bladder cancer correlate with tumor grade and invasion
9. 72-Kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: A clinicopathologic, immunohistochemical, and Serological study
10. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury
11. Production of extracellular matrix-degrading proteinases of primary cultures of human epithelial ovarian carcinoma cells
12. Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer
13. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms
14. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: Clinical and prognostic implications
15. Time-resolved immunofluorometric assay of trypsin-2 complexed with a-1-antitrypsin in serum
16. 1-antitrypsin in serum: Increased immunoreactivity in patients with biliary tract cancer
17. Trypsinogen expression in human ovarian carcinomas
18. Differential expression of trypsin in human ovarian carcinomas and low-malignant-potential tumors
19. Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase
20. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies
21. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors
22. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis
23. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity
24. Production of trypsins by human gastric cancer cells correlates with their malignant phenotype
25. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase
26. Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of pro-urokinase
27. Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2
28. Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix
29. Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen
30. Identification of one-and two-chain forms of trypsinogen I produced by a human gastric adenocarcinoma cell line
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
32. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma
33. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
34. Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: Association with reduced cancer cell migration
35. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
36. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
37. Stimulation of cellular growth and adhesion to fibronectin and vitronectin in culture and tumorigenicity in nude mice by overexpression of trypsinogen in human gastric cancer cells
38. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma
39. Expression and activity of MMPS and their regulators in ovarian cancer
40. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer
41. Acute pancreatitis. Biochemical, pathophysiological and therapeutical aspects
42. Optimization of a time-resolved immunofluorometric assay for tumor-associated trypsin inhibitor (TATI) using the streptavidin-biotin system
43. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
44. A matrix metalloproteinase expressed on the surface of invasive tumour cells
45. Activation of type IV procollagenases by human tumor-associated trypsin-2
46. Biology and function of tumor-associated trypsin inhibitor. TATI
47. Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas
48. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlate with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis
49. Proteolytic degradation of extracellular matrix in tumor invasion
50. Laminin in the human embryo implantation: Analogy to the invasion by malignant cells
51. Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in gynecologic tumors
52. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma
53. Pre-operative serum level of tumour-associated trypsin inhibitor and residual tumor size as prognostic indicators in Stage III epithelial ovarian cancer
54. Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse
55. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2)